Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
2019
New Developments in Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) and Mismatch Repair Gene Testing
2006
Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis
2012
Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
2010
Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer
2007
TFOS DEWS II Clinical Trial Design Report
2017
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
2009
Rheumatoid arthritis
2018 Standout
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
2013
Microsatellite Instability in Colorectal Cancer
2010 Standout
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
2015 Nature
Rheumatoid arthritis
2016 Standout
Small Targeted Cytotoxics: Current State and Promises from DNA‐Encoded Chemical Libraries
2013
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
The scent of disease: volatile organic compounds of the human body related to disease and disorder
2011 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
2019
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
2016
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Encoded libraries of chemically modified peptides
2015 StandoutNobel
COVID-19: A promising cure for the global panic
2020 Standout
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
2016 Standout
Active-comparator design and new-user design in observational studies
2015
Psoriasis
2021 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Forget personalised medicine and focus on abating disease activity
2012
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
2008
The immune system in atherosclerosis
2011 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
2016
Colorectal cancer screening with odour material by canine scent detection
2011
Lower Gastrointestinal Tract Cancer Predisposition Syndromes
2010
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
European biologicals registers: methodology, selected results and perspectives
2008
Ulcerative colitis
2016 Standout
Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome
2009
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
2020
Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial
2010
Rheumatoid arthritis
2010 Standout
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
2018
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
2015
Hidradenitis suppurativa
2020 Standout
Ulcerative colitis
2020 Standout
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
2017
Mind and body: how the health of the body impacts on neuropsychiatry
2013
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Surgery in ulcerative colitis: When? How?
2018
Psoriasis
2016
The FDA-approved drug sofosbuvir inhibits Zika virus infection
2016
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic
2008
Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
2011
Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter
2006
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
2011
Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer
2014
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
2014
Psoriasis Pathogenesis and Treatment
2019 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE)
2016
Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience
2018
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
2017
Etanercept for the treatment of rheumatoid arthritis
2013
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
2009
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Etanercept for the Treatment of Rheumatoid Arthritis
2018
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Comparative Effectiveness of Anti–Tumor Necrosis Factor Drugs on Health‐Related Quality of Life Among Patients With Inflammatory Arthritis
2013
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM
2019
Association of Tobacco Exposure and Reduction of Radiographic Progression in Early Rheumatoid Arthritis: Results From a French Multicenter Cohort
2013
Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid Arthritis
2015
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Industry sponsorship and research outcome
2017 Standout
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment
2016
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Wietske Kievit being referenced
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
2013
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritis
2007
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies
2008
Determinants Associated with Work Participation in Patients with Established Rheumatoid Arthritis Taking Tumor Necrosis Factor Inhibitors
2014
Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls
2015
Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice
2010
Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment
2011
Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
2012
Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
2012
Prior Colorectal Neoplasia Is Associated With Increased Risk of Ileoanal Pouch Neoplasia in Patients With Inflammatory Bowel Disease
2013
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
2015
Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis
2016
Effectiveness of a Third Tumor Necrosis Factor-α-blocking Agent Compared with Rituximab After Failure of 2 TNF-blocking Agents in Rheumatoid Arthritis
2011
Cost effectiveness of a new strategy to identify HNPCC patients
2004
The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
2012
Current clinical selection strategies for identification of hereditary non‐polyposis colorectal cancer families are inadequate: a meta‐analysis
2004
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
2015
Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review
2015
The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data
2008
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice
2007
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort
2016
Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.
2014
Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis
2015
Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long‐term results from the Bio‐CAPTURE registry
2014
An increased risk of non‐melanoma skin cancer during TNF ‐inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease‐related factors
2014
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
2016
[More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
2005
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
2018
Determinants of drug survival for etanercept in a long‐term daily practice cohort of patients with psoriasis
2013